Transdermal nicotine in smoking cessation. A meta-analysis

Area of Science:

• Pharmacology and Therapeutics
• Addiction Medicine
• Clinical Research

Background:

• Smoking remains a leading cause of preventable morbidity and mortality worldwide.
• Nicotine replacement therapy (NRT) is a widely used strategy to aid smoking cessation.
• Transdermal nicotine patches deliver nicotine continuously, offering a potential method for managing nicotine dependence.

Purpose of the Study:

• To systematically review and statistically analyze clinical trial data on transdermal nicotine patches for smoking cessation.
• To determine the pooled efficacy of transdermal nicotine in achieving both short-term and long-term smoking abstinence.
• To evaluate the incidence and nature of adverse effects associated with transdermal nicotine patch use.

Main Methods:

• Systematic literature search to identify relevant clinical trials on transdermal nicotine.
• Detailed statistical analysis using fixed effect and random effects models to calculate pooled estimates.
• Calculation of pooled odds ratios (OR) and risk differences (RD) for smoking cessation outcomes.

Main Results:

• Transdermal nicotine patches demonstrated significant effectiveness for short-term cessation (OR = 3.10, RD = 0.25) and long-term cessation (OR = 2.26, RD = 0.11).
• Long-term abstinence rates were higher in the nicotine patch group compared to placebo.
• Skin irritation was a frequent adverse effect, reported in up to 70% of users; other adverse effects were generally minor and transient.

Conclusions:

• Transdermal nicotine patches are an effective aid for smoking cessation, supporting both short-term and long-term abstinence.
• While generally well-tolerated, skin irritation can be significant, potentially limiting use in sensitive individuals.
• Further research is warranted to assess the efficacy of nicotine patches in community settings and without professional medical support.